NIVABUPABSENIVA BUPA HEALTH INS CO L· InsuranceHighNeutral
Announced Thu, 30 Jul, 2026 · 16:03 IST

Q1 FY27 results approved; board clears up to 500 crore rupees NCD issuance

Emphasis Of MatterResults View source PDFExplain this filing

NIVABUPA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+0.2%Reaction day
₹86.40
prior close
₹89.61
announcement price
After-mkt
timing
Nifty Smallcap 250market+0.4%-0.3% vs market
General Insurance peers, median of 5sector-0.2%+0.4% vs sector

On the reaction day the stock moved 0.3 pts less than Nifty Smallcap 250 and 0.4 pts more than its General Insurance peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-2.1
10m
-2.5
15m
-2.5
30m
-3.9
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+0.2+0.4-0.3-0.2+0.4
Next day
-0.5+1.8-2.3+2.6-3.1
2d
+1.0+2.0-0.9+0.8+0.2
3d
+1.3+2.7-1.4+2.3-1.0
4d
+0.9+2.9-2.0+1.6-0.7
5d
-0.1+2.9-3.0+0.1-0.2
1w
-1.3+3.0-4.3+0.5-1.8
15d
-4.8+3.2-8.0-0.2-4.6
1m
-6.5+3.0-9.5-0.5-6.0
2m
-14.4-0.3-14.1-2.6-11.8
3m
—————
UpDownMarket · Nifty Smallcap 250Sector · General Insurance peers, median of 5Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Niva Bupa board approved unaudited Q1 FY27 results (quarter ended June 30, 2026). Joint auditors S.R. Batliboi and Nangia and Co issued a clean limited review report, with one emphasis of matter. Board also approved raising up to 500 crore rupees via listed, rated, unsecured, subordinated, redeemable non-convertible debentures on private placement in one or more tranches. A Debt Raising Committee was formed to finalise terms. Auditors flagged that the company has applied for IRDAI forbearance on expenses exceeding allowable limits for FY 2024-25, with approval pending.

Likely market impact

Clean result clearance supports sentiment, but the auditor flag on pending IRDAI expense approval is a watch point. Debt raise of 500 crore rupees lifts capital but adds interest obligations.